FFA
AUPH icon

Farther Finance Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Farther Finance Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$54.7K Buy
3,378
+382
+13% +$6.09K ﹤0.01% 3336
2026
Q2 		$50.8K Buy
2,996
+774
+35% +$12.4K ﹤0.01% 3229
2026
Q1 		$34.4K Sell
2,222
-268
-11% -$3.92K ﹤0.01% 3258
2025
Q4 		$39.7K Buy
2,490
+425
+21% +$6.03K ﹤0.01% 2968
2025
Q3 		$22.8K Buy
2,065
+2,047
+11,372% +$22.4K ﹤0.01% 2954
2025
Q2 		$152 Hold
18
– – ﹤0.01% 4250
2025
Q1 		$145 Hold
18
– – ﹤0.01% 4011
2024
Q4 		$162 Sell
18
-10
-36% -$82 ﹤0.01% 3703
2024
Q3 		$205 Sell
28
-55
-66% -$341 ﹤0.01% 3645
2024
Q2 		$456 Buy
83
+68
+453% +$358 ﹤0.01% 3303
2024
Q1 		$81 Sell
15
-42
-74% -$285 ﹤0.01% 3413
2023
Q4 		$512 Buy
+57
New +$469 ﹤0.01% 2971

Other funds holding AUPH

JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors's AUPH Position: Q3 2026 in Review

Farther Finance Advisors increased its Aurinia Pharmaceuticals (AUPH) stake by 13% in Q3 2026, buying an estimated $6.09K and bringing the position to 3,378 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3336.

Farther Finance Advisors first reported a position in AUPH in Q4 2023 and has held it in 12 quarters since. 7 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Farther Finance Advisors held 3,378 shares of Aurinia Pharmaceuticals worth $54.7K as of Q3 2026.
  • Farther Finance Advisors bought 382 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $6.09K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3336 holding.
  • Farther Finance Advisors first reported a position in Aurinia Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 7 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.